ENLIGHT-LN Trademark

Trademark Overview


On Friday, February 4, 2022, a trademark application was filed for ENLIGHT-LN with the United States Patent and Trademark Office. The USPTO has given the ENLIGHT-LN trademark a serial number of 97253225. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Wednesday, March 27, 2024. This trademark is owned by Aurinia Pharmaceuticals Inc.. The ENLIGHT-LN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical research services; medical research and development in the field of lupus nephritis; providing medical and scientific research information in the field of clinical trials; scientific research, namely, conducting clinical trials for others in the field of lupus nephritis
enlight-ln

General Information


Serial Number97253225
Word MarkENLIGHT-LN
Filing DateFriday, February 4, 2022
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateWednesday, March 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 25, 2023

Trademark Statements


Description of MarkThe mark consists of the wording "ENLIGHT-LN" in stylized form to the right of a radiating light bulb.
Pseudo MarkENLIGHTEN
Goods and ServicesMedical research services; medical research and development in the field of lupus nephritis; providing medical and scientific research information in the field of clinical trials; scientific research, namely, conducting clinical trials for others in the field of lupus nephritis

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, February 9, 2022
Primary Code042
First Use Anywhere DateMonday, November 30, 2020
First Use In Commerce DateMonday, November 30, 2020

Trademark Owner History


Party NameAurinia Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressVictoria, B.C. V8Z7X8
CA

Party NameAurinia Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressVictoria, B.C. V8Z7X8
CA

Trademark Events


Event DateEvent Description
Thursday, March 28, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, March 27, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, March 22, 2024STATEMENT OF USE PROCESSING COMPLETE
Thursday, February 29, 2024USE AMENDMENT FILED
Thursday, March 21, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 29, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, September 19, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, August 31, 2023ASSIGNED TO EXAMINER
Tuesday, July 25, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 25, 2023PUBLISHED FOR OPPOSITION
Wednesday, July 5, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 22, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 23, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 22, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 22, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 22, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 22, 2022NON-FINAL ACTION E-MAILED
Tuesday, November 22, 2022NON-FINAL ACTION WRITTEN
Thursday, November 17, 2022ASSIGNED TO EXAMINER
Thursday, February 10, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, February 9, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 8, 2022NEW APPLICATION ENTERED